GCDH and hepatocellular carcinoma: Our results showed that overexpression of GCDH decreased the phosphorylation of ATR (p-Ser428) and CHK1 (p-Ser345), key markers of ATR pathway activation, and led to a marked decrease in RAD51 expression in HCC cells.